Скачать или смотреть Timing Matters in Prediabetes Remission, with Arvid Sandforth, MD

Achieving early remission of prediabetes to normal glucose regulation during lifestyle intervention offered additional protective benefits for preventing T2D compared with late remission, according to new research presented by Arvid Sandforth, MD, physician scientist, Institute of Diabetes Research and Metabolic Diseases, Tübingen, Germany, at the 2025 ADA Scientific Sessions meeting.

The analysis compared, from a prediabetes lifestyle intervention study, responders that returned to normal glycemia at an early time point after 6 months, participants that reached remission after 12 months, and participants that never reached remission. Both responder groups at 6 and 12 months experienced a protective effect against T2D, but the group that reached early remission was even better off than the ones reaching later remission.

“The most important part is to be aware that early detection matters and to be aware that remission is attainable, right? It's a target that's worth striving for. And also, I think, having this in mind, providing people with resources that the patients help themselves [with is important],” Sandforth told HCPLive.

Read more: https://www.hcplive.com/view/timing-m...